King Luther Capital Management Corp Sells 73,626 Shares of Zoetis Inc. $ZTS

King Luther Capital Management Corp lowered its position in Zoetis Inc. (NYSE:ZTS – Free Report) by 16.2% in the 3rd quarter, Holdings Channel reports. The fund owned 379,539 shares of the company’s stock after selling 73,626 shares during the quarter. King Luther Capital Management Corp’s holdings in Zoetis were worth $26,503,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Valmark Advisers Inc. boosted its position in shares of Zoetis by 7.7% during the first quarter. Valmark Advisers Inc. now owns 1,747 shares of the company’s stock valued at $207,000 after purchasing an additional 125 shares in the last quarter. Balefire LLC lifted its position in Zoetis by 6.7% during the first quarter. Balefire LLC now owns 1,996 shares of the company’s stock valued at $236,000 after buying an additional 125 shares during the period. Greenleaf Trust boosted its holdings in shares of Zoetis by 2.9% during the 2nd quarter. Greenleaf Trust now owns 4,763 shares of the company’s stock valued at $342,000 after buying an additional 134 shares in the last quarter. Financial Solutions Advisory Group Inc. grew its position in shares of Zoetis by 1.1% in the 3rd quarter. Financial Solutions Advisory Group Inc. now owns 15,697 shares of the company’s stock worth $1,096,000 after buying an additional 170 shares during the period. Finally, 71 West Capital Partners increased its stake in shares of Zoetis by 6.6% in the 2nd quarter. 71 West Capital Partners now owns 2,823 shares of the company’s stock worth $203,000 after acquiring an additional 175 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ZTS. Jefferies Financial Group lifted their price target on shares of Zoetis from $83.00 to $85.00 in a research report on Friday, November 6th. Weiss Ratings raised shares of Zoetis from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday, October 29th. Zacks Research upgraded shares of Zoetis from a “strong sell” rating to a “hold” rating in a report on Monday, October 26th. JPMorgan Chase & Co. dropped their price target on Zoetis from $130.00 to $115.00 and set an “overweight” rating on the stock in a research report on Friday, August 7th. Finally, Stifel Nicolaus dropped their price target on Zoetis from $85.00 to $80.00 and set a “hold” rating on the stock in a research report on Thursday, August 20th. Eight investment analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $101.25.

Check Out Our Latest Report on ZTS

Zoetis Price Performance

Shares of NYSE:ZTS opened at $82.59 on Thursday. Zoetis Inc. has a 1-year low of $68.77 and a 1-year high of $132.49. The company has a debt-to-equity ratio of 2.51, a current ratio of 2.35 and a quick ratio of 1.40. The business has a fifty day moving average price of $75.99 and a 200-day moving average price of $91.97. The company has a market capitalization of $33.56 billion, a PE ratio of 12.44, a PEG ratio of 1.19 and a beta of 0.67.

Zoetis (NYSE:ZTS – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $1.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.51 by $0.24. The firm had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.30 billion. Zoetis had a return on equity of 85.90% and a net margin of 26.15%. Zoetis’s quarterly revenue was down 1.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.70 EPS. As a group, equities analysts expect that Zoetis Inc. will post 6.29 EPS for the current fiscal year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 1st. Stockholders of record on Friday, October 30th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, October 30th. Zoetis’s dividend payout ratio is currently 36.05%.

Zoetis Profile

(Free Report)

Zoetis is an animal health company that discovers, develops, manufactures and markets medicines, vaccines, diagnostic products and other services for animals. Its products support both companion animals, such as dogs and cats, and livestock, including cattle, pigs, poultry, sheep and fish. The company’s offerings include treatments for pain, infections and skin conditions, as well as vaccines, parasiticides, diagnostic tools and genetic testing services. Zoetis serves veterinarians, livestock producers and other animal health professionals around the world.

Featured Articles

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS – Free Report).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.